6th Orphan Drugs and Rare Diseases Europe 2017 Berlin, Germany 15-16 May 2017

Description:
SMi's 6th annual Orphan Drugs and Rare Diseases event will be taking place in Europe's largest pharmaceutical market, Berlin on 15th - 16th May 2017.

Rare diseases have long been under researched, with many unaware that such conditions even existed. However recent advancements within the orphan drugs landscape has resulted in a significant growth, with the market expected to reach a record breaking $191 billion by 2019. Conversely, there cannot be success without challenges.

With Germany currently possessing one of the toughest pricing mechanisms and policies in Europe, this two day conference will endeavor to establish an interactive platform exploring how payers, pharma, biotech and patient organisations are preparing to participate and leverage the rapidly growing orphan drugs and rare diseases market.

Price:
Book by 31 Jan: GBP 1099
Book 28 Feb: GBP 1299
Book 31 Mar: GBP 1399
Standard Price: GBP 1499

Speakers: Aegerion Pharmaceuticals, Institute of Pharmaceutical Research and Technology, Therachon AG, Novo Nordisk, Orphan Europe, SYMPTOMA, Alexion Pharma GmbH, ATAXIA UK and many more